期刊文献+

肝癌细胞系Huh-7中EpCAM^+细胞亚群的肿瘤干细胞样特性 被引量:2

Cancer stem cell-like properties of EpCAM^+ cell subpopulation in hepatocellular carcinoma cell line Huh-7
下载PDF
导出
摘要 目的:观察从肝癌细胞系Huh-7中分选出的EpCAM+细胞亚群的肿瘤干细胞样特性。方法:采用免疫磁珠法从Huh-7细胞中分离EpCAM+和EpCAM-细胞亚群,比较其体外增殖、克隆形成、分化、耐药和体内成瘤能力。结果:EpCAM+细胞体外增殖能力强于EpCAM-细胞(P<0.001);EpCAM+细胞克隆形成数高于EpCAM-细胞(P<0.001);分选后随着培养时间的延长,EpCAM+细胞的比率逐渐降低;加入顺铂培养后,EpCAM+细胞亚群的比率增加(P<0.001);1×103个EpCAM+细胞接种裸鼠皮下4周即可成瘤,而在相同条件下,EpCAM-细胞至少需要接种1×105个和接种更长的时间才能成瘤。结论:EpCAM+细胞亚群具有肝癌干细胞样特性,EpCAM可作为分离纯化肝癌干细胞的一个标志物。 Aim:To observe the properties of epithelial cell adhesion molecule(EpCAM)-positive cell subpopulation sorted from human hepatocellular carcinoma cell line Huh-7.Methods:EpCAM+ and EpCAM-subpopulations were isolated by automagnetic activated cell-sorting system and their abilities of proliferation,differentiation,colony formation,resistance to cisplatin and tumorgenicity were observed.Results:The cell proliferation ability of EpCAM+ subpopulation was stronger than that of EpCAM-subpopulation(P0.001).The number of colonies formed by EpCAM+ subpopulations was more than that of EpCAM-subpopulations(P0.001).The proportion of EpCAM+ cells in sorted subpopulation decreased gradually as the cells were cultured.After Huh-7 cells were cultured with cisplatin,the percentage of EpCAM+ cells increased(P0.001).Only 103 EpCAM+ cells were enough to form tumors in nude mice after subcutaneous inoculation for four weeks,while 105 EpCAM-cells were necessary to form tumors.Conclusion:EpCAM+ subpopulation sorted from Huh-7 has properties of liver cancer stem cell.EpCAM might be a valuable marker for isolating and purifying hepatocellular carcinoma stem cells.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2012年第3期306-309,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省基础与前沿计划基金资助项目072300450060 河南省医学攻关计划基金资助项目200703087
关键词 肝癌 肿瘤干细胞 上皮细胞黏附分子 liver cancer cancer stem cell epithelial cell adhesion molecule
  • 相关文献

参考文献12

  • 1Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells[J]. Science,1977,197(4302):461.
  • 2Spizzo G, Fong D, Wurm M, et al. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis [ J ]. J Clin Pathol, 2011,64 ( 5 ) :415.
  • 3Marquardt JU, Factor VM, Thorgeirsson SS. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications [ J ]. J Hepatol, 2010,53 (3) :568.
  • 4McDonahl SA, Graham TA, Schier S, et al. Stem cells and solid cancers[J]. Virchows Arch, 2009, 455 ( 1 ) : 1.
  • 5Todaro M, Francipane MG, Medema JP, et al. Colon cancer stem cells : promise of targeted therapy [ J ]. Gastroenterology,2010,138(6) :2151.
  • 6Xie ZC. Brain tumor stem cell [J]. Neurochem Res, 2009,34(12) :2055.
  • 7Suetsugi A, Nagaki M, Aoki H, et al. Characterization of CD 1 3 3 + hepatocellular carcinoma cells as cancer stem /progenitor cells [ J ]. Biochem Biophys Res Commun, 2006, 351(4):820.
  • 8Yang ZF, Ho DW, Ng MN. Significance of CD90^+ cancer stem cells in human liver cancer [ J ]. Cancer Cell, 2008, 13(2) :153.
  • 9Haraguchi N, Ishii H, Mimori K, et al. CD13 is a therapeutic target in human liver cancer stem cells [J]. J Clin Invest,2010,120(9) :3326.
  • 10Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer [Jl. Bri J Cancer,2007,96(3):417.

同被引文献27

  • 1Sano T, Izuishi K, Takebayashi R, et al. Surgical approach for extrahepatic metastasis of HCC in the abdominal cavity [J]. Hepatogastroenterology, 2011, 58(112): 2067-2070.
  • 2Zhao X, Li J, He Y, et al. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma[J]. Cancer Res, 2001, 61(20): 7383-7387.
  • 3Gan Y, Zhao X, Hu J, et al. HCCS1 overexpression induces apoptosis via cathepsin D and intracellular calcium, and HCCS 1 disruption in mice causes placental abnormality[J]. Cell Death Differ, 2008, 15(9): 1481-1490.
  • 4Xiao-Yong S, Zhi-Feng L, Fan-Zhen L, et al. Expression and clinical significance of HCCS 1 in non-small cell lung cancer[J]. Contemp Oncol (Pozn), 2012, 16(4): 328-331.
  • 5Gan Y, Zhao X, Hu J, et at. Adenovirus-mecliated HCSCSI overexpression elicits a potent antitumor efficacy on human colorectal cancer and hepatoma cells both in vitro and in vivo[J]. Cancer Gene Ther, 2008, 15(12): 808-816.
  • 6Xu HN, Huang WD, Cai 3(, et al. HCCSl-armed, quadruple- regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy[J]. Mol Cancer, 2011, 10: 133.
  • 7Song S, Shen X, Tang Y, et al. Sinomenine pretreatment attenuates cold ischemia/reperfusion injury in rats: the role of heme oxygenase- 1 [J]. Int Immunopharmacol, 2010, 10(6): 679-684.
  • 8Gangopadhyay S, Nandy A, Hor P, et al. Breast cancer stem cells: a novel therapeutic target[J]. Clin Breast Cancer, 2013, 13(1): 7-15.
  • 9Tu SM, Lin SH. Prostate cancer stem cells[J]. Clin Genitourin Cancer, 2012, 10(2): 69-76.
  • 10Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells perspecrives on current status and future directions: AACR Workshop on cancer stem cells[J]. Cancer Res, 2006, 66(19): 9339-9344.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部